| | Class 2 Device Recall RNeasy DSP FFPE Kit |  |
| Date Initiated by Firm | May 06, 2019 |
| Create Date | June 28, 2019 |
| Recall Status1 |
Terminated 3 on April 23, 2020 |
| Recall Number | Z-1891-2019 |
| Recall Event ID |
82985 |
| PMA Number | P180043 |
| Product Classification |
System, blood collection, rna stabilization, rna purification, rt-pcr molecular diagnostic test - Product Code NTW
|
| Product | RNeasy DSP FFPE Kit (48), REF 73604 - Product Usage: The RNeasy DSP FFPE Kit is a system intended for the purification of total RNA from formalin-fixed, paraffin embedded (FFPE) tissues. The product is intended to be used by professional users, such as technicians and physicians that are trained in molecular biological techniques. It deploys an optimized silica spin-column-based protocol, and includes enzymatic removal of residual DNA. The RNeasy DSP FFPE Kit is intended for in vitro diagnostic use. |
| Code Information |
LOT 163016105 |
| FEI Number |
3003572099
|
Recalling Firm/ Manufacturer |
Qiagen Sciences, Inc. 19300 Germantown Rd Germantown MD 20874-1415
|
| For Additional Information Contact | QIAGEN Technical Services 800-362-7737 |
Manufacturer Reason for Recall | The deparaffinization solution contains a contaminant, which leads to reduced lysis efficiency of the affected lot, resulting in significantly reduced yields and less sensitive downstream applications. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | Urgent Notice of Product Field Action dated 5/6/19 were emailed to customers. |
| Quantity in Commerce | 31 |
| Distribution | US nationwide distribution in the states of MA, RI, AZ, NY, NC, IN, TX.
The products were distributed to the following foreign countries: Germany, Great Britain, Italy, France, Sweden, and Switzerland. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|